Warfarin Patient Self-management Implementation in the US Healthcare System
Overcoming Barriers to Warfarin Patient Self-management Implementation in the US Healthcare System
University of Utah
150 participants
Mar 15, 2023
INTERVENTIONAL
Conditions
Summary
In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.
Eligibility
Inclusion Criteria6
- At least 18 years of age treated with warfarin for any indication for at least 9 months prior to enrollment
- Demonstrate the willingness and ability to test their own INR using a home INR monitoring device or have same-day access to clinic-derived INR results (e.g., via electronic medical record secure messaging)
- Willing to make independent decisions about warfarin dosing based on INR results
- Able to perform INR tests at least every 2 weeks
- Currently have and willing to maintain internet access for the duration of the study in order to complete online data collection forms
- Have an anticipated duration of warfarin therapy of at least 6 months
Exclusion Criteria4
- Goal INR range other than 2.0-3.0 or 2.5-3.5
- Known poor adherence to warfarin therapy
- Non-English speaking
- Inability or refusal to provide written informed consent
Interventions
Patient makes independent decisions regarding warfarin therapy changes using warfarin dosing tools
Normal care provided by anticoagulation providers
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04766216